Factor XIII, Functional
Also known as: Factor XIII Activity, Factor XIII Inhibitor, Functional, Fibrin Stabilizing Factor
Use
Low Factor XIII levels, i.e., <15%, may cause a bleeding disorder and levels <2% have been associated with spontaneous intracranial hemorrhage.
Special Instructions
Not provided.
Limitations
This test was performed using a kit that has not been cleared or approved by the FDA. The analytical performance characteristics of this test have been determined by Quest Diagnostics. This test should not be used for diagnosis without confirmation by other medically established means.
New York Approved
Methodology
Other
Biomarkers
Result Turnaround Time
2-9 days
Related Documents
For more information, please review the documents below
Specimen
Plasma
Volume
1 mL
Minimum Volume
0.3 mL
Container
plastic vial (platelet‑poor plasma)
Collection Instructions
Collect light blue top (3.2% sodium citrate) tube; centrifuge 15 minutes at approx. 1500 g within 60 minutes. Remove plasma avoiding buffy coat; centrifuge again; transfer 1 mL platelet‑poor plasma.
Storage Instructions
Freeze immediately.
Causes for Rejection
Thawed plasma
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 24 hours |
| Refrigerated | 24 hours |
| Frozen | 14 days |